NexaBiome enters partnership with JAFRAL for industrial-scale phage production

Pioneering UK biotech company NexaBiome has partnered with industry giant, JAFRAL, to propel the development of NexaBiome’s technology for industrial-scale production of immobilised bacteriophage. The agreement signed between the two companies will enable production capacity to be significantly ramped up, with a hundredfold increase – creating the potential to treat millions of patients with phage-based…


Fixed Phage rebrands to NexaBiome Limited, signifying commitment towards human health sector

  UK-based biotechnology company Fixed Phage has changed its name to NexaBiome Limited, pushing forward in its promise to connect science, technology and healthcare to address the global challenge of antimicrobial resistance (AMR), especially in human health. NexaBiome’s pioneering work in addressing bacterial issues will also continue in the animal and veterinary health sector, cementing…